Attwood Science 290(5491):471-473, Oct. 27, 2000.* |
GBTRANS Database, Accession No. AF172398 (blast results) (Direct Submission Feb. 26, 2001). |
GBTRANS Database, Accession No. AF191495 (blast results) (Direct Submission Oct. 1, 1999). |
GBTRANS Database, Accession No. AJ132502, “HSA132502_1 Z39Ig protein—Homo sapiens” (blast results) (Direct Submission Jan. 25, 1999). |
GBTRANS Database, Accession No. AL034397, “HS159A1_1 dA159A1.1 (novel protein)—Homo sapiens” (blast results) (Direct Submission Dec. 4, 1998). |
GBTRANS Database, Accession No. AL136649, “HSM801619_1 hypothetical protein” (blast results) (Direct Submission Jan. 18, 2000). |
GBTRANS Database, Accession No. AY016009 (blast results) (Direct Submission Dec. 4, 2000). |
GENESEQ Patent Database, Accession No. P_B19396 (blast results) (Oct. 19, 2000). |
GENESEQ Patent Database, Accession No. P_B24047 (blast results) (Sep. 14, 2000). |
GENESEQ Patent Database, Accession No. P_B24401 (blast results) (Jun. 8, 2000). |
GENESEQ Patent Database, Accession No. P_B24405 (blast results) (Jun. 8, 2000). |
GENESEQ Patent Database, Accession No. P_B33421 (blast results) (Sep. 14, 2000). |
GENESEQ Patent Database, Accession No. P_B33429 (blast results) (Sep. 14, 2000). |
GENESEQ Patent Database, Accession No. P_B44247 (bast results) (Sep. 14, 2000). |
GENESEQ Patent Database, Accession No. P_B53081 (blast results) (Sep. 14, 2000). |
GENESEQ Patent Database, Accession No. P_B53086 (blast results) (Sep. 14, 2000). |
GENESEQ Patent Database, Accession No. P_B55950 (blast results) (Nov. 23, 2000). |
GENESEQ Patent Database, Accession No. P_B56015 (blast results) (Nov. 23, 2000). |
GENESEQ Patent Database, Accession No. P_W61379 (blast results) (Jun. 11, 1998). |
GENESEQ Patent Database, Accession No. P_W74464 (blast results) (Jan. 21, 1999). |
GENESEQ Patent Database, Accession No. P_W75220 (blast results) (Sep. 17, 1998). |
GENESEQ Patent Database, Accession No. P_W85457 (blast results) (Oct. 1, 1998). |
GENESEQ Patent Database, Accession No. P_Y08060 (blast results) (Mar. 25, 1999). |
GENESEQ Patent Database, Accession No. P_Y08071 (blast results) (Mar. 25, 1999). |
GENESEQ Patent Database, Accession No. P_Y08072 (blast results) (Mar. 25, 1999). |
GENESEQ Patent Database, Accession No. P_Y08074 (blast results) (Mar. 25, 1999). |
GENESEQ Patent Database, Accession No. P_Y13354 (blast results) (Mar. 25, 1999). |
GENESEQ Patent Database, Accession No. P_Y13364 (blast results) (Mar. 25, 1999). |
GENESEQ Patent Database, Accession No. P_Y23321 (blast results) (Jun. 3, 1999). |
GENESEQ Patent Database, Accession No. P_Y23322 (blast results) (Jun. 3, 1999). |
GENESEQ Patent Database, Accession No. P_Y23324 (blast results) (Jun. 3, 1999). |
GENESEQ Patent Database, Accession No. P_Y23326 (blast results) (Jun. 3, 1999). |
GENESEQ Patent Database, Accession No. P_Y23328 (blast results) (Jun. 3, 1999). |
GENESEQ Patent Database, Accession No. P_Y41691 (blast results) (Sep. 16, 1999). |
GENESEQ Patent Database, Accession No. P_Y70668 (blast results) (Mar. 23, 2000). |
GENESEQ Patent Database, Accession No. P_Y70670 (blast results) (Mar. 23, 2000). |
GENESEQ Patent Database, Accession No. P_Y7601 (blast results) (Nov. 4, 1999). |
GENESEQ Patent Database, Accession No. P_Y76076 (blast results) (Nov. 4, 1999). |
GENESEQ Patent Database, Accession No. P_Y95344 (blast results) (Jun. 29, 2000). |
GENESEQ Patent Database, Accession No. P_Y95346 (blast results) (Jun. 29, 2000). |
REFSEQ Database, Accession No. NM_016946 (blast results) (1999). |
REFSEQ Database, Accession No. NM_021219 (blast results) (2000). |
Swissprot (SPROT) Database, Accession No. P57087, “VEJA_HUMAN Vascular endothelial junction-associated molecule precursor—Homo sapiens” (blast results) (2000). |
Swissprot (SPROT) Database, Accession No. Q9Y624, “JAM_HUMAN Junctional adhesion molecule precursor—homo sapiens” (blast results) (1999). |
Alderson et al., “Molecular and biological characterization of human 4-1BB and its ligand” European Journal of Immunology 24(9):2219-2227 (Sep. 1994). |
Altschul et al., “Local alignment statistics” Methods in Enzymology 266:460-480 (1996). |
Auffray et al., “H. sapiens partial cDNA sequence; clones c-0xdl0. partial cDNA sequence; transcribed sequence fragment” (DATABASE EMBL—EMEST16 Accession No. F02373) (Jan. 28, 1995). |
Chambers and Allison, “Co-stimulation in T cell responses” Current Opinion in Immunology 9(3):396-404 (Jun. 1997). |
DeSmet et al., “The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation” Proc. Natl. Acad. Sci. USA 93(14):7149-7153 (Jul. 9, 1996). |
Finn and Lotze, “Third Keystone Symposium on Cellular Immunology and the Immunotherapy of Cancer. Introduction” Journal of Immunotherapy 21(2):114-118 (Mar. 1998). |
Heath et al., “The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily” Proc. Natl. Acad. Sci. USA 94(2):469-474 (Jan. 21, 1997). |
Hellstrom and Hellstrom, “T cell immunity to tumor antigens” Critical Reviews in Immunology 18(1-2):1-6 (1998). |
Hiller et al., “zb18h08.rl Soares fetal lung NbHL19W Homo sapiens cDNA clone 302463 5′” (Database EMBL—EMEST13 Accession No. W17367) (May 4, 1996). |
Hiller et al., “zd74g06.rl Soares fetal heart NbHH19W Homo sapiens cDNA clone 346426 5′” (Database EMBL—EMEST14 Accession No. W79882) (Jun. 27, 1996). |
“Isolation of Mouse Mononuclear Cells” Current Protocols in Immunology, Coligan et al. eds., John Wiley & Sons, Inc. vol. 1:unit 3.1.2 (1993). |
Jenkins, M., “The ups and downs of T cell costimulation” Immunity 1(6):443-446 (Sep. 1994). |
June et al., “The B7 and CD28 receptor families” Immunology Today 15(7):321-331 (Jul. 1994). |
Kwon et al., “Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer” Proc. Natl. Acad. Sci. USA 94(15):8099-8103 (Jul. 22, 1997). |
Linsley and Ledbetter, “The role of the CD28 receptor during T cell responses to antigen” Annual Review of Immunology 11:191-212 (1993). |
Lynch et al., “Flt3 ligand induces tumor regression and antitumor immune responses in vivo” Nature Medicine 3(6):625-631 (Jun. 1997). |
Martin-Padura et al., “Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration” Journal of Cell Biology 142(1):117-127 (Jul. 13, 1998). |
Melero et al., “Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors” Nature Medicine 3(6):682-685 (Jun. 1997). |
Monks et al., “Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines” Journal of the National Cancer Institute 83(11):757-766 (Jun. 5, 1991). |
Schwartz, R., “Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy” Cell 71(7):1065-1068 (Dec. 24, 1992). |
Skehan et al., “New colorimetric cytotoxicity assay for anticancer-drug screening” Journal of the National Cancer Institute 82(13):1107-1112 (Jul. 4, 1990). |
Walunas et al., “CTLA-4 can function as a negative regulator of T cell activation” Immunity 1(5):405-413 (Aug. 1994). |
Welt et al., “Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer” Journal of Clinical Oncology 12(8):1561-1571 (Aug. 1994). |
Welt et al., “Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33” Journal of Clinical Oncology 8(11):1894-1906 (Nov. 1990). |